Acura Pharmaceuticals Inc (ACUR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2010 | 06-2010 | 03-2010 | 12-2009 | 09-2009 | |
| Sales | 292 | 620 | 2,040 | 750 | 808 |
| Gross Profit | 292 | 620 | 2,040 | 750 | 808 |
| Operating Expenses | 2,858 | 3,806 | 6,075 | 4,827 | 4,778 |
| Operating Income | -2,566 | -3,186 | -4,035 | -4,077 | -3,970 |
| Other Income | 15 | -3 | 5 | 13 | 20 |
| Pre-tax Income | -2,551 | -3,189 | -4,030 | -4,064 | -3,950 |
| Income Tax | 2 | 3 | 5 | 20 | 4 |
| Net Income Continuous | -2,553 | -3,192 | -4,035 | -4,084 | -3,954 |
| Net Income | $-2,553 | $-3,192 | $-4,035 | $-4,084 | $-3,954 |
| EPS Basic Total Ops | -0.25 | -0.35 | -0.45 | -0.45 | -0.45 |
| EPS Basic Continuous Ops | -0.27 | -0.34 | -0.43 | -0.44 | -0.43 |
| EPS Diluted Total Ops | -0.25 | -0.35 | -0.45 | -0.45 | -0.45 |
| EPS Diluted Continuous Ops | -0.27 | -0.34 | -0.43 | -0.44 | -0.43 |
| EBITDA(a) | $-2,533 | $-3,153 | $-4,000 | $-4,043 | $-3,938 |